Fig. 1From: Interim 4′-[methyl-11C]-thiothymidine PET for predicting the chemoradiotherapeutic response in head and neck squamous cell carcinoma: comparison with [18F]FDG PETPlot of individual baseline and interim PET parameters, according to the therapy response in 32 patients with HNSCCBack to article page